Sun Pharmaceutical Industries informs about press release

14 Sep 2023 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a Press Release relating to licensing agreement between Sun Pharma and Pharmazz Inc. for introducing Tyvalzi™ (Sovateltide) in India.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma Inds. Share Price

1736.85 6.90 (0.40%)
12-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1736.85
Dr. Reddys Lab 1215.65
Cipla 1466.05
Zydus Lifesciences 895.00
Lupin 2189.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×